Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.992
+0.011 (1.16%)
At close: Dec 5, 2025, 4:00 PM EST
0.975
-0.017 (-1.71%)
After-hours: Dec 5, 2025, 6:58 PM EST
Oncolytics Biotech Market Cap
Oncolytics Biotech has a market cap or net worth of $105.31 million as of December 5, 2025. Its market cap has increased by 28.90% in one year.
Market Cap
105.31M
Enterprise Value
97.04M
1-Year Change
28.90%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since September 30, 2002, Oncolytics Biotech's market cap has increased from $30.90M to $105.31M, an increase of 240.80%. That is a compound annual growth rate of 5.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 102.80M | 46.02% |
| Dec 31, 2024 | 70.40M | -25.27% |
| Dec 29, 2023 | 94.20M | -0.95% |
| Dec 30, 2022 | 95.10M | 24.48% |
| Dec 31, 2021 | 76.40M | -24.21% |
| Dec 31, 2020 | 100.80M | -15.44% |
| Dec 31, 2019 | 119.20M | 341.48% |
| Dec 31, 2018 | 27.00M | -60.93% |
| Dec 29, 2017 | 69.10M | 178.63% |
| Dec 30, 2016 | 24.80M | -1.59% |
| Dec 31, 2015 | 25.20M | -43.88% |
| Dec 31, 2014 | 44.90M | -62.24% |
| Dec 31, 2013 | 118.90M | -57.43% |
| Dec 31, 2012 | 279.30M | 5.40% |
| Dec 30, 2011 | 265.00M | -35.74% |
| Dec 31, 2010 | 412.40M | 260.49% |
| Dec 31, 2009 | 114.40M | 129.72% |
| Dec 31, 2008 | 49.80M | -20.70% |
| Dec 31, 2007 | 62.80M | -17.04% |
| Dec 29, 2006 | 75.70M | -49.09% |
| Dec 30, 2005 | 148.70M | 19.06% |
| Dec 31, 2004 | 124.90M | 47.81% |
| Dec 31, 2003 | 84.50M | 194.43% |
| Dec 31, 2002 | 28.70M | -7.12% |
View and export this data all the way back to 2002.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 901.37B |
| Johnson & Johnson | 487.33B |
| AbbVie | 400.08B |
| UnitedHealth Group | 299.79B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 248.65B |
| Abbott Laboratories | 217.93B |